As part of the ongoing review of clinical policies for all the NHS Clinical Commissioning Groups (CCGs) in Lancashire and South Cumbria and following the statutory guidance issued by NHS England around 17 procedures included in their Evidence Based Interventions (EBI) guidance, we are now seeking your feedback on one additional clinical policy. This is a new clinical policy for 6 of our CCGs.
The patient access criteria for this policy has already been through a public consultation and been made mandatory guidance to Clinical Commissioning Groups. We are not therefore, seeking feedback on the criteria as this cannot be changed. The engagement being undertaken is to inform you about the new policy and to give you the opportunity to comment on any adverse impact you feel this will have and what the CCG should do to minimise this.
The clinical policy open for patient and public feedback is the policy for ganglia excision.
The policy can be found below. You are invited to read the clinical policy before giving your feedback. You can click on the link next to the policy in order to complete a short survey and give your views.
Chorley South Ribble and Greater Preston CCGs already have a ganglia excision policy, but they have chosen to adopt the NHS England EBI criteria to align the policy with the other CCGs. The policies are not widely different but the EBI criteria has a broader scope and more detail. Residents of these CCG areas are also encouraged to provide their feedback. You can read the level of change document for these CCGs here.
Your comments will be fed back to the CCGs as part of the implementation process.
Your feedback for this policy should be submitted by Wednesday 13 February 2019.
Once you have read the new policy you can provide feedback through this online survey
If you have any further questions about this policy or the process being undertaken you can email email@example.com or ring 01772 214244.
If you require any of these documents in an alternative format such as Braille, larger print, audio, British Sign Language or in a language other than English please contact the Customer Care Team in one of the following ways:
Further opportunities will be made available for your involvement and feedback on other clinical policies as and when they are developed and available for discussion.
Frequently asked questions
These frequently asked questions are supplementary to the FAQ’s already identified as part of the clinical policy review process.